Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03983395
Title Study of GBR 1302 (CD3 Bispecific Ab) in HER2-positive Metastatic Breast Cancer
Recruitment Terminated
Gender female
Phase Phase Ib/II
Variant Requirements No
Sponsors Glenmark Pharmaceuticals S.A.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.